Diabetic nephropathy

• Exploring the Therapeutic Potential of Cannabinoid Receptor Antagonists in Inflammation, Diabetes Mellitus, and Obesity (02 Sep 2024)
  
• Cannabinoid Signaling in Kidney Disease (29 Aug 2024)
  
• A genome-wide association study identifies a possible role for cannabinoid signalling in the pathogenesis of diabetic kidney disease (29 Aug 2024)
  
• Cannabinoid Receptor 1 Inhibition in Chronic Kidney Disease: A New Therapeutic Toolbox (20 Aug 2024)
  
• MicroRNA-29a Attenuates Diabetic Glomerular Injury through Modulating Cannabinoid Receptor 1 Signaling (19 Aug 2024)